Liver cancer: Effects, safety, and cost-effectiveness of controlled- release oxycodone for pain control after TACE

Radiology

Volumn 262, Issue 3, 2012, Pages 1014-1021

  Zhou, Bo ^a   Wang, Jianhua ^a   Yan, Zhiping ^a   Shi, Peng ^a   Kan, Zuxing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FENTANYL; MORPHINE; OXYCODONE; PLACEBO;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CHEMOEMBOLIZATION; CONSTIPATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSURIA; FEMALE; HUMAN; HYPERSOMNIA; INOPERABLE CANCER; LENGTH OF STAY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PAIN; PREMEDICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VOMITING;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXYCODONE; PAIN MANAGEMENT; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84863354703     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110552     Document Type: Article

References (27)

1. Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30(1):6-25. (Pubitemid 44900485)
2. Wulf H, Neugebauer E. Guidelines for postoperative pain therapy. Curr Opin Anaesthesiol 1997;10(5):380-385. (Pubitemid 27468680)
3. Ross FB, Wallis SC, Smith MT. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 2000;84(2-3):421-428. (Pubitemid 30074246)
4. Levy MH. Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain 2001;5(Suppl A):113-116.
5. Austin KL, Stapleton JV, Mather LE. Multiple intramuscular injections: a major source of variability in analgesic response to meperidine. Pain 1980;8(1):47-62. (Pubitemid 10169089)
6. Sinatra RS, Torres J, Bustos AM. Pain management after major orthopaedic surgery: current strategies and new concepts. J Am Acad Orthop Surg 2002;10(2):117-129.
7. Mucci-LoRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 1998;2(3):239-249. (Pubitemid 28474354)
8. Reuben SS, Steinberg RB, Maciolek H, Joshi W. Preoperative administration of controlled-release oxycodone for the management of pain after ambulatory laparoscopic tubal ligation surgery. J Clin Anesth 2002;14(3):223-227. (Pubitemid 34556726)
9. Reuben SS, Connelly NR, Maciolek H. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery. Anesth Analg 1999;88(6):1286-1291. [Published retraction appears in Shafer SL. Anesth Analg 2009;108(4):1350.] (Pubitemid 29246939)
10. Kampe S, Warm M, Kaufmann J, Hundegger S, Mellinghoff H, Kiencke P. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer. Curr Med Res Opin 2004;20(2):199-202. (Pubitemid 38197321)
11. Kaufmann J, Yesiloglu S, Patermann B, Krombach J, Kiencke P, Kampe S. Controlled- release oxycodone is better tolerated than intravenous tramadol/metamizol for postoperative analgesia after retinal-surgery. Curr Eye Res 2004;28(4):271-275. (Pubitemid 38491320)
12. Blumenthal S, Min K, Marquardt M, Borgeat A. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Anesth Analg 2007;105(1):233-237.
13. Gammaitoni AR, Galer BS, Bulloch S, et al. Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10 mg/acetaminophen 325 mg versus controlled-release oxycodone 20 mg in postsurgical pain. J Clin Pharmacol 2003;43(3):296-304. (Pubitemid 36232659)
14. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf. Published 2006. Accessed December 2, 2008.
15. Fanelli G, Ghisi D, Berti M, et al. Preoperative administration of controlled-release oxycodone as a transition opioid for total intravenous anaesthesia in pain control after laparoscopic cholecystectomy. Surg Endosc 2008;22(10):2220-2228.
16. Ginsberg B, Sinatra RS, Adler LJ, et al. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting. Pain Med 2003;4(1):31-38.
17. Koizumi W, Toma H, Watanabe K, et al. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Jpn J Clin Oncol 2004;34(10):608-614. (Pubitemid 40662716)
18. Hale M, Tudor IC, Khanna S, Thipphawong J. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended- release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. Clin Ther 2007;29(5):874-888. (Pubitemid 47223433)
19. Rauck RL, Bookbinder SA, Bunker TR, et al. A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial. J Opioid Manag 2007;3(1):35-43. (Pubitemid 350199792)
20. Gatti A, Sabato AF, Occhioni R, Colini Baldeschi G, Reale C. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009;61(3):129-137.
21. Nicholson B, Ross E, Sasaki J, Weil A. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled- release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin 2006;22(8):1503-1514. (Pubitemid 44297429)
22. Afilalo M, Etropolski MS, Kuperwasser B, et al. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig 2010;30(8):489-505.
23. Marcus DA, Glick RM. Sustained-release oxycodone dosing survey of chronic pain patients. Clin J Pain 2004;20(5):363-366. (Pubitemid 39108850)
24. Pan H, Zhang Z, Zhang Y, et al. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clin Drug Investig 2007;27(4):259-267. (Pubitemid 46440298)
25. Kampe S, Wolter K, Warm M, Dagtekin O, Shaheen S, Landwehr S. Clinical equivalence of controlled-release oxycodone 20 mg and controlled-release tramadol 200 mg after surgery for breast cancer. Pharmacology 2009;84(5):276-281.
26. Dickenson AH. Plasticity: implications for opioid and other pharmacological interventions in specific pain states. Behav Brain Sci 1997;20(3):392-403; discussion 435-513.
27. Woolf CJ, Wall PD. Morphine-sensitive and morphine-insensitive actions of C-fibre input on the rat spinal cord. Neurosci Lett 1986;64(2):221-225. (Pubitemid 16158431)